[go: up one dir, main page]

NO20003096L - Sammensetninger og fremgangsmÕter for behandling av ADD - Google Patents

Sammensetninger og fremgangsmÕter for behandling av ADD

Info

Publication number
NO20003096L
NO20003096L NO20003096A NO20003096A NO20003096L NO 20003096 L NO20003096 L NO 20003096L NO 20003096 A NO20003096 A NO 20003096A NO 20003096 A NO20003096 A NO 20003096A NO 20003096 L NO20003096 L NO 20003096L
Authority
NO
Norway
Prior art keywords
compositions
methods
treating add
treating
add
Prior art date
Application number
NO20003096A
Other languages
English (en)
Other versions
NO329974B1 (no
NO20003096D0 (no
Inventor
Juan Mantelle
Terese A Dixon
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26750154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003096(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of NO20003096D0 publication Critical patent/NO20003096D0/no
Publication of NO20003096L publication Critical patent/NO20003096L/no
Publication of NO329974B1 publication Critical patent/NO329974B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
NO20003096A 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD. NO329974B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6951097P 1997-12-15 1997-12-15
US09/163,351 US6210705B1 (en) 1997-12-15 1998-09-30 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
PCT/US1998/026560 WO1999030694A2 (en) 1997-12-15 1998-12-14 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Publications (3)

Publication Number Publication Date
NO20003096D0 NO20003096D0 (no) 2000-06-15
NO20003096L true NO20003096L (no) 2000-08-15
NO329974B1 NO329974B1 (no) 2011-01-31

Family

ID=26750154

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003096A NO329974B1 (no) 1997-12-15 2000-06-15 Sammensetning for topisk applikasjon av metylfenidat, og anvendelse av metylfenidat i fremstillingen av et fleksibelt, endelig system for behandling av ADHD og ADD.

Country Status (28)

Country Link
US (2) US6210705B1 (no)
EP (2) EP1037615B1 (no)
JP (3) JP4316800B2 (no)
KR (1) KR100633348B1 (no)
CN (1) CN1368876A (no)
AR (1) AR014062A1 (no)
AT (1) ATE260652T1 (no)
AU (1) AU752027B2 (no)
BR (1) BR9814282A (no)
CA (1) CA2315237C (no)
CZ (2) CZ2009132A3 (no)
DE (1) DE69822199T2 (no)
DK (1) DK1037615T3 (no)
ES (2) ES2452517T3 (no)
HK (2) HK1049447A1 (no)
HU (1) HU226615B1 (no)
IL (1) IL136760A0 (no)
LV (1) LV12558B (no)
NO (1) NO329974B1 (no)
NZ (1) NZ505689A (no)
PE (1) PE20000120A1 (no)
PL (1) PL195315B1 (no)
PT (1) PT1037615E (no)
RU (1) RU2233156C2 (no)
SI (1) SI20360B (no)
TR (1) TR200001736T2 (no)
TW (2) TWI242452B (no)
WO (1) WO1999030694A2 (no)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
GB9913458D0 (en) * 1999-06-09 1999-08-11 Medeva Europ Ltd The therapeutic use of d-threo-methylphenidate
GB9918735D0 (en) * 1999-08-09 1999-10-13 Straken Limited Transdermal patches
CO5261532A1 (es) * 1999-11-15 2003-03-31 Novartis Ag Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
ATE252903T1 (de) * 1999-12-17 2003-11-15 Celltech Pharma Europ Ltd Arzneimittel zur behandlung konvulsivischer zustände
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
WO2002069942A1 (fr) * 2001-03-07 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. Timbre adhesif
FR2822049B1 (fr) * 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
ES2270746T3 (es) * 2001-03-16 2007-12-01 Alza Corporation Parche transdermico para administrar fentanilo.
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20030049272A1 (en) * 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
MEP23508A (en) * 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
AU2006206410B2 (en) * 2005-01-20 2012-08-30 Ampio Pharmaceuticals, Inc. Methylphenidate derivatives and uses of them
ATE517623T1 (de) * 2005-01-20 2011-08-15 Inst Molecular Medicine Inc Verwendung von methylphenidat-derivaten
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
AU2007221117A1 (en) * 2006-02-27 2007-09-07 Noven Pharmaceuticals, Inc. Transdermal therapeutic system comprising scopolamine
ES2352696T3 (es) * 2006-05-01 2011-02-22 Colgate-Palmolive Company Composición para la higiene bucal con material compuesto de silicona.
WO2008103538A1 (en) * 2007-02-21 2008-08-28 Connected Health Systems, Llc Treating adhd and other diseases involving inflammation
US20090258061A1 (en) * 2007-10-15 2009-10-15 Johnson & Johnson Once-a-day replacement transdermal administration of fentanyl
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2924350B1 (fr) * 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
JP2011507665A (ja) * 2007-12-31 2011-03-10 アクラレント インコーポレイテッド 粘膜組織包帯剤及び使用方法
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5155128B2 (ja) * 2008-12-11 2013-02-27 日東電工株式会社 メチルフェニデート貼付製剤
CA2759107C (en) * 2009-06-05 2017-10-03 Megtec Systems, Inc. Improved infrared float bar
EP2364695A1 (en) 2010-02-10 2011-09-14 Nitto Denko Corporation Methylphenidate patch preparation
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
KR20160135373A (ko) 2011-03-23 2016-11-25 아이언쇼어 파마슈티컬즈 앤드 디벨롭먼트, 인크. 주의력 결핍 장애의 치료를 위한 방법 및 조성물
US9079928B2 (en) * 2011-07-28 2015-07-14 Kempharm, Inc. Methylphenidate-oxoacid conjugates, processes of making and using the same
AR092999A1 (es) 2012-10-15 2015-05-13 Noven Pharma Composiciones y metodos para la administracion transdermica de metilfenidato
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
MX366230B (es) 2012-12-28 2019-07-03 Noven Pharma Composiciones multipolimericas para liberación transdermica de farmaco.
TW201431554A (zh) 2012-12-28 2014-08-16 Noven Pharma 左炔諾孕酮（ｌｅｖｏｎｏｒｇｅｓｔｒｅｌ）及乙烯雌二醇之經皮藥物遞送系統
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US11337936B2 (en) 2013-03-14 2022-05-24 Noven Pharmaceuticals, Inc. Amphetamine transdermal compositions with acrylic block copolymer
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
EP2983468A4 (en) 2013-03-15 2016-09-07 Durect Corp COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
JP6518397B2 (ja) 2013-12-25 2019-05-22 株式会社フジモト・コーポレーション 注意欠如・多動性障害の予防および治療剤
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
CN106511264A (zh) * 2016-11-15 2017-03-22 北京万全德众医药生物技术有限公司 一种盐酸哌甲酯口服溶液剂及其制备方法
CN110234636B (zh) 2016-12-11 2022-09-20 坎普哈姆公司 包含哌醋甲酯前药的组合物，其制造和使用方法
EP3598982A1 (en) 2018-07-23 2020-01-29 Centre National De La Recherche Scientifique Bioconjugates of neuropeptides derivatives
JP7600661B2 (ja) 2020-12-11 2024-12-17 ａｒｔｉｅｎｃｅ株式会社 貼付剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
AU1992592A (en) * 1991-05-24 1993-01-08 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5629019A (en) 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
WO1994002176A1 (en) 1992-07-28 1994-02-03 The Procter & Gamble Company Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
CH691209A5 (de) 1993-09-06 2001-05-15 Scherrer Inst Paul Herstellungsverfahren für einen Polmerelektrolyten und elektrochemische Zelle mit diesem Polymerelektrolyten.
ES2139778T3 (es) 1994-06-29 2000-02-16 Hennecke Gmbh Procedimiento y dispositivo para la fabricacion continua de bloques o bandas de material de espuma.
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
WO1998039042A1 (en) 1997-03-07 1998-09-11 Jackson Richard R Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
GB9711032D0 (en) 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
EP1710504A2 (en) 1999-12-15 2006-10-11 Osaka Gas Co., Ltd. Burner Apparatus, Gas Turbine Engine and Cogeneration System

Also Published As

Publication number Publication date
US6210705B1 (en) 2001-04-03
BR9814282A (pt) 2000-10-03
DK1037615T3 (da) 2004-07-12
PT1037615E (pt) 2004-07-30
US6348211B1 (en) 2002-02-19
NZ505689A (en) 2003-01-31
AU1824999A (en) 1999-07-05
HU226615B1 (en) 2009-04-28
SI20360A (sl) 2001-04-30
HK1049447A1 (zh) 2003-05-16
TW200406231A (en) 2004-05-01
HK1156872A1 (en) 2012-06-22
JP4316800B2 (ja) 2009-08-19
HUP0004539A3 (en) 2006-06-28
ES2219926T3 (es) 2004-12-01
WO1999030694A3 (en) 1999-08-19
WO1999030694A2 (en) 1999-06-24
TWI242452B (en) 2005-11-01
KR100633348B1 (ko) 2006-10-16
CA2315237C (en) 2009-12-01
DE69822199D1 (de) 2004-04-08
CZ300535B6 (cs) 2009-06-10
HUP0004539A2 (hu) 2001-06-28
CZ305817B6 (cs) 2016-03-23
EP2314288A1 (en) 2011-04-27
JP2009073856A (ja) 2009-04-09
LV12558B (en) 2001-03-20
RU2233156C2 (ru) 2004-07-27
NO329974B1 (no) 2011-01-31
NO20003096D0 (no) 2000-06-15
PL195315B1 (pl) 2007-08-31
EP1037615B1 (en) 2004-03-03
LV12558A (lv) 2000-11-20
KR20010033114A (ko) 2001-04-25
AU752027B2 (en) 2002-09-05
JP2002510600A (ja) 2002-04-09
SI20360B (sl) 2008-06-30
CN1368876A (zh) 2002-09-11
TWI244396B (en) 2005-12-01
DE69822199T2 (de) 2005-02-17
PE20000120A1 (es) 2000-02-19
CA2315237A1 (en) 1999-06-24
CZ20002209A3 (cs) 2000-11-15
TR200001736T2 (tr) 2001-01-22
ES2452517T3 (es) 2014-04-01
JP2013056944A (ja) 2013-03-28
IL136760A0 (en) 2001-06-14
AR014062A1 (es) 2001-01-31
ATE260652T1 (de) 2004-03-15
EP2314288B1 (en) 2013-12-11
PL341596A1 (en) 2001-04-23
CZ2009132A3 (cs) 2016-03-23
EP1037615A2 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO991676D0 (no) FremgangsmÕter og sammensetninger for immunmodulering
NO20012916L (no) Sammensetninger og fremgangsmåter for behandling av anorektale forstyrrelser
DE69834401D1 (de) Businterfacesystem und verfahren
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
EP1014995A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING RESTENOSES CONSECUTIVE TO REVASCULARIZATION INTERVENTIONS
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
DK0804078T3 (da) Sammensætning og anvendelse deraf
PT956294E (pt) Inibidores da trombina
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
ZA981600B (en) Methods and compositions for treating stickies
NO996090D0 (no) Forbedret foskefor og fremgangsmåte for anvendelse av dette
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
DE69924489D1 (de) Getreide-beta-glukanzusammensetzungen und verfahren
FI965008A (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
ID19570A (id) Metode merawat tanaman kotiledonous
DE69708418D1 (de) Naphthylverbindungen und Zusammensetzungen
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO964485D0 (no) Fremgangsmåte for stabilisering av forbindelsen DX-52-1 og lyofilisert sammensetning derav
ID16838A (id) Komposisi dekafluoropentana
DE69731574D1 (de) Kompiliergerät und -verfahren
NO975178D0 (no) Belegningsblanding og anvendelse av denne
ID17941A (id) Metode penerapan komposisi pembuat marka jalan

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees